Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's disease
- 18 February 2000
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 280 (2), 119-122
- https://doi.org/10.1016/s0304-3940(00)00767-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Variability in Annual Mini-Mental State Examination Score in Patients With Probable Alzheimer DiseaseArchives of Neurology, 1999
- Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer DiseaseArchives of Neurology, 1999
- Cerebrospinal fluid A?42 is increased early in sporadic Alzheimer's disease and declines with disease progressionAnnals of Neurology, 1999
- High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E GenotypeArchives of Neurology, 1998
- Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up studyJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's diseaseNeurology, 1997
- Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele ϵ4 during 14 months follow-upNeuroscience Letters, 1996
- Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's diseaseAnnals of Neurology, 1995
- Alzheimer pathology of patients carrying apoliprotein E ε4 alleleNeurobiology of Aging, 1995
- Increased levels of τ protein in cerebrospinal fluid of patients with alzheimer's disease—correlation with degree of cognitive impairmentAnnals of Neurology, 1995